Metastatic Pancreatic Cancer: Case 1
Larry D, a 62-year-old, presented to his primary care physician with persistent pain in his epigastric region, which persists throughout the night. Within the past 2 years, he has developed diabetes and experienced considerable weight loss with signs of depression.
- During his visit, jaundice was observed along with periumbilical subcutaneous metastases.
- Testing revealed an elevated CA19-9 level (2293 U/ml).
- CT scan showed a large mass on the head of the pancreas, and a subsequent biopsy showed the mass to be adenocarcinoma. Liver and local lymph note metastases were identified.
Larry went on to receive the combination of nab-paclitaxel and gemcitabine as frontline therapy for 5 months:
- Upon progression, Larry was switched to the combination of liposomal irinotecan, fluorouracil, and folinic acid. Treatment failure occurred after 2.5 months.
- Larry received FOLFOX as a third-line treatment.